Error message

The page you requested does not exist. For your convenience, a search was performed using the query trials canc 4687 javelin ovarian 200 b9991009.

Search results

  1. Dr Alasdair Russell

    ... we use these novel models in a range of pre-clinical trials to advance our understanding of disease. ...

  2. Dr Amos Burke

    ... role he is responsible for the delivery of clinical cancer trials for Children and Young People in England. ...

  3. Mr Angelos Kolias

    ... but the main emphasis is on the conduct of randomised trials. For his methodological work, he is collaborating with the IDEAL group ... is the Co-Chief Investigator of four NIHR-funded randomised trials and the Associate Director of the NIHR Global Health Research Group on ...

  4. Dr Basma Greef

    ... develop new treatments. My other interests include clinical trials and the effective management of toxicities related to widely used ...

  5. Dr Brent O'Carrigan

    - Phase 2/3 clinical trials in renal cancer and melanoma ...

  6. Dr Bristi Basu

    ... findings on lead candidate agents into early phase clinical trials of novel therapeutic drugs as chief investigator, principal investigator ... and industry-sponsored Phase I, II and III clinical trials, including first-in-human and first-in-class studies. My tumour ...

  7. Professor Charlotte Coles

    ... of recurrence. She is Chief Investigator of 4 clinical trials with linked translational research: 1. IMPORT LOW : phase III ...

  8. Ms Ceilidh Welsh

    ... from nearly 3000 patients recruited across radiotherapy trials in Breast Cancer, Prostate Cancer and Head & Neck Cancer. ...

  9. Dr Danish Mazhar

    ... He is the Principal Investigator of numerous clinical trials in Prostate, Bladder and Testis Cancers. He is a member of National ...

  10. Dr David Gilligan

    ... tract cancer and is an enthusiastic participator in clinical trials. He has been a member of the NCRI Lung Cancer Studies Group. He is ...

  11. Dr Ali Amin Al Olama

    My research has focused on discovery of genetic risk factors of prostate cancer through genome-wide association studies and fine-mapping. I am a core member of an international consortium PRACTICAL (Prostate Cancer Association Group to Investigate...

  12. Dr Andreas Bender

    Previously affiliated with the Lead Discovery Informatics (LDI) group of Novartis in Cambridge/MA, I am now developing and applying cheminformatics techniques in the drug discovery field in my group with the University of Cambridge. Our expertise ranges...

  13. Dr Alejandra Bruna

    We aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in the regulation of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the...

  14. Professor Antonis Antoniou

    My main research interest is the development and application of statistical modelling techniques for addressing clinical questions, and the development of risk prediction tools which are used in clinical practice. ...

  15. Dr Catherine Lindon

    My lab studies cell division in human cells, with particular focus on regulation by ubiquitin-mediated proteolysis. We use time-lapse fluorescence imaging of live cells to measure proteolysis of substrates in real time, and to study the role of...

  16. Dr Alison Dunning

    Work in the Centre for Cancer Genetic Epidemiology "wet lab" involves running very high throughput SNP-chip genotyping and Next Generation Sequencing (NGS) studies. We search for genetic risk factors for both cancer susceptibility and treatment-response...

  17. Dr Ashray Gunjur

    I am an early-career medical oncologist from Melbourne, Australia. I am broadly interested in immuno-oncology and the link between cancer and the gut microbiome, and am undertaking a PhD supervised by Dr David Adams and Dr Trevor Lawley (Wellcome...

  18. Dr Ahsan MEMON

    Ahsan has developed a sui generis versatile holographic system capable of diverse photo-perturbation techniques including photo-manipulation, photo-activation, photo-ablation, optical-trapping and optogenetics, combined with multi-modal imaging...

  19. Dr Aisling Redmond

    Aisling received her undergraduate degree in Genetics from Trinity College Dublin and PhD from Dublin City University. She completed postdoctoral fellowships in the breast cancer field at the Royal College of Surgeons in Ireland and Cancer Research UK...

  20. Professor Alan Warren

    Our long-term goal is to elucidate the molecular mechanisms of ribosome assembly in eukaryotic cells and to understand how defects in this process cause bone marrow failure and cancer predisposition. Assembly of the two subunits of the ribosome,...

  21. Dr Anna Piskorz

    ... focus on translational research in high grade serous ovarian cancer (HGSOC). I work on identification of genomic biomarkers that ...

  22. Dr Daniel Barnes

    ... These individuals are at increased risk of breast cancer and ovarian cancer in women, and breast cancer and prostate cancer in men. I am ...

  23. Professor Steve Charnock-Jones

    ... underlying the progression from endometriosis to clear cell ovarian cancer.  Endometriosis is a relatively common condition affecting ... of these cases there is an increased incidence of clear cell ovarian cancer.  Recent work has shown that mutations in Arid1a gene are ...

  24. Professor Evis Sala

    Now based in Rome, my research in Cambridge focused on integrated diagnostics, through the clinical development and validation of functional imaging biomarkers to rapidly evaluate treatment response using physiologic and metabolic tumour habitat imaging...

  25. Dr Geoff Macintyre

    ... associated with treatment resistance in high-grade serous ovarian cancer (HGSOC). These methods are developed using whole-genome ...

  26. Dr Honglin Song

    I am working on genetic susceptibility to the risk of ovarian cancer and clinical outcome after a diagnosis of ovarian cancer. I have led the work of the group in common/rare gene variation ...

  27. Professor James Brenton

    ... clinical trials with sequential collection and profiling of ovarian cancer tissues before and during therapy. Array-based expression ...

  28. Miss Alicia Gonzalez Diaz

  29. Mr Arman Ghodsinia

  30. Professor Tony Green

    Tony Green is Professor of Haemato-oncology in the University of Cambridge and honorary Consultant Haematologist at Addenbrookes Hospital. He was appointed Head of the University Department of Haematology (2000-2020), and in 2016 was appointed Director...

  31. Mr Asif Jah

    Mr Asif Jah ...

  32. Professor Bertie Gottgens

    The Göttgens group uses a combination of experimental and computational approaches to study how transcription factor networks control the function of blood stem cells and how mutations that perturb such networks cause leukaemia. This integrated approach...

  33. Dr Cedric Ghevaert

    Cedric Gevaert graduated from the medical school of the University Libre de Bruxelles in 1997 and subsequently became a fellow of the Royal College of Physicians, London (2000). He specialised in Haematology and became a fellow of the Royal College of...

  34. Dr David Adams

    ... Consortium and aims to generate phenotyping data for over 200 genetically modified mouse lines per year to gain a better understanding of ...

Pages